购物车
- 全部删除
- 您的购物车当前为空
M2698 (MSC2363318A) 是 p70S6K、Akt1 和 Akt3 的抑制剂,IC50 为 1 nM。 M2698 显示出抗癌活性。
为众多的药物研发团队赋能,
让新药发现更简单!
M2698 (MSC2363318A) 是 p70S6K、Akt1 和 Akt3 的抑制剂,IC50 为 1 nM。 M2698 显示出抗癌活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 437 | 现货 | |
5 mg | ¥ 1,090 | 现货 | |
10 mg | ¥ 1,730 | 现货 | |
25 mg | ¥ 2,910 | 现货 | |
50 mg | ¥ 4,130 | 现货 | |
100 mg | ¥ 5,590 | 现货 | |
200 mg | ¥ 7,530 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,230 | 现货 |
产品描述 | M2698 (MSC2363318A) is an inhibitor of p70S6K, Akt1 and Akt3 with IC50s of 1 nM. M2698 shows anti-cancer activity. |
靶点活性 | Akt1:1 nM, p70 S6K:1 nM, Akt3:1 nM |
体外活性 | M2698 (0.3 nM-50 M) dose-dependently inhibits proliferation in breast tumor cell lines (IC50s: 0.02-8.5 µM). M2698 (0.3-1 µM) induces feedback loop phosphorylation on Akt and suppresses Akt and p70S6K activity in HCC1419 and MDA-MB-453 cells. M2698 inhibits indirectly pGSK3β and pS6 with IC50s of 17 and 15 nM[1]. |
体内活性 | Gavage administration of M2698 (10-30 mg/kg) dose-dependently inhibits the growth of tumors and increases pAkt levels in tumor tissue. M2698 (30 mg/kg) causes tumor regression. M2698 (1-20 mg/kg) inhibits S6 phosphorylation in a dose-proportional manner over time[1]. |
别名 | MSC2363318A |
分子量 | 449.86 |
分子式 | C21H19ClF3N5O |
CAS No. | 1379545-95-5 |
Smiles | N([C@H](CN1CCC1)C2=CC(C(F)(F)F)=C(Cl)C=C2)C=3C4=C(C(C(N)=O)=CC=C4)N=CN3 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 112.5 mg/mL (250.1 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容